Nicolas Duployez (@nicolasduployez) 's Twitter Profile
Nicolas Duployez

@nicolasduployez

#leusm #AMLsm #MDSsm molecularist & #Blood cytologist 🔬/ #Myeloid neoplasms and #germline disorders / #Hematology department @CHU_Lille @univ_lille

ID: 1102819356046708736

linkhttps://www.webofscience.com/wos/author/record/268798 calendar_today05-03-2019 06:33:18

338 Tweet

536 Followers

457 Following

Nicolas Duployez (@nicolasduployez) 's Twitter Profile Photo
Nicolas Duployez
@nicolasduployez

10 months ago

📍ELN 2017/2022 prognostic classifiers did not adequately stratify OS outcomes for #AMLsm patients treated with VEN-based regimens. 📍A 4-gene prognostic model (TP53, FLT3-ITD, NRAS, and KRAS) stratified OS outcomes with VEN-AZA treatment in #AMLsm. ashpublications.org/blood/article/…

📍ELN 2017/2022 prognostic classifiers did not adequately stratify OS outcomes for #AMLsm patients treated with VEN-based regimens. 📍A 4-gene prognostic model (TP53, FLT3-ITD, NRAS, and KRAS) stratified OS outcomes with VEN-AZA treatment in #AMLsm. ashpublications.org/blood/article/…